Whitehawk Therapeutics Inc (WHWK) Stock Price & Growth Analysis

Quote Panel

Updated October 19, 2025

1W 8.33 % 1M 16.32 % 3M 19.46 % 1Y 5.24 %

Key Metrics

Market Cap
104.15M
Shares Outstanding
47.13M
Share in Float
18.95M
Dividende
0

Earning Date
05 Nov 2025
Price Target
2.21
Average Volume
1.62M
Beta
0.66

Range
1.39-3.812
Industry
Biotechnology
Website
https://ir.whitehawktx.com
Sector
Healthcare

Quote Panel

Updated October 19, 2025

1W % 1M % 3M % 1Y %

Key Metrics

Market Cap
Shares Outstanding
Share in Float
Dividende

Earning Date
No Data
Price Target
Average Volume
Beta

Range
Industry
Website
Sector

Fundamentals

N/A

P/E Ratio

4.82x

P/S Ratio

0.89x

P/B Ratio

0.0

Debt/Equity

-48.2%

Net Margin

$-0.8

EPS

How WHWK compares to sector?

P/E Ratio

Fundamentals

Relative Strength

WHWK

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Relative Strength

WHWK

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

$37M

415%

2026-Revenue

$1.57

-106%

2026-EPS

$31M

-415%

2026-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Price Target

N/A(N/A)

Number of analyst

N/A

Last analyst upgrade/downgrade

No Data Available

Forecast

Analyst rating

Last analyst upgrade/downgrade

Earnings Growth

YoY

Current

Estimates

Q3.23

N/A

NA
vs NA

Q4.23

N/A

NA
vs NA

Q1.24

N/A

NA
vs NA

Q2.24

N/A

NA
vs NA

Q3.24

N/A

NA
vs NA

Q4.24

N/A

-0.67
vs NA

Q1.25

N/A

-0.36
vs NA

Q2.25

N/A

-0.76
vs NA

Q3.25

N/A

-0.51
vs NA

Q4.25

N/A

-0.69
vs -0.67

Sales Growth

YoY

Current

Estimates

Q2.23

+80%

6.2M vs 3.4M

Q3.23

+40%

6M vs 4.2M

Q4.23

+21%

6.3M vs 5.2M

Q1.24

-9%

5.4M vs 5.9M

Q2.24

6.2M vs 6.2M

Q3.24

+21%

7.2M vs 6M

Q4.24

+14%

7.2M vs 6.3M

Q1.25

+33%

7.1M vs 5.4M

Q2.25

-100%

NA vs 6.2M

Q3.25

+362%

33.3M vs 7.2M

Return on Equity

QoQ

Q1.23

-10%

-0.10
vs -0.09

Q2.23

-14%

-0.14
vs -0.10

Q3.23

-14%

-0.14
vs -0.14

Q4.23

-15%

-0.15
vs -0.14

Q1.24

-20%

-0.20
vs -0.15

Q2.24

-19%

-0.19
vs -0.20

Q3.24

-18%

-0.18
vs -0.19

Q4.24

-35%

-0.35
vs -0.18

Q1.25

+33%

0.33
vs -0.35

Q2.25

-31%

-0.31
vs 0.33

Institutionnal Ownership

N/A

Q3.23

NA
vs NA

Q4.23

NA
vs NA

Q1.24

NA
vs NA

Q2.24

NA
vs NA

Q3.24

NA
vs NA

Q4.24

NA
vs NA

Q1.25

NA
vs NA

Q2.25

NA
vs NA

Q3.25

NA
vs NA

Q4.25

NA
vs NA

Earnings Growth

YoY

Current

Estimates

Q3.23

N/A

NA
vs NA

Q4.23

N/A

NA
vs NA

Q1.24

N/A

NA
vs NA

Q2.24

N/A

NA
vs NA

Q3.24

N/A

NA
vs NA

Q4.24

N/A

-0.67
vs NA

Q1.25

N/A

-0.36
vs NA

Q2.25

N/A

-0.76
vs NA

Q3.25

N/A

-0.51
vs NA

Q4.25

N/A

-0.69
vs -0.67

Sales Growth

YoY

Current

Estimates

Q2.23

+80%

6.2M vs 3.4M

Q3.23

+40%

6M vs 4.2M

Q4.23

+21%

6.3M vs 5.2M

Q1.24

-9%

5.4M vs 5.9M

Q2.24

6.2M vs 6.2M

Q3.24

+21%

7.2M vs 6M

Q4.24

+14%

7.2M vs 6.3M

Q1.25

+33%

7.1M vs 5.4M

Q2.25

-100%

NA vs 6.2M

Q3.25

+362%

33.3M vs 7.2M

Return on Equity

QoQ

Q1.23

-10%

-0.10
vs -0.09

Q2.23

-14%

-0.14
vs -0.10

Q3.23

-14%

-0.14
vs -0.14

Q4.23

-15%

-0.15
vs -0.14

Q1.24

-20%

-0.20
vs -0.15

Q2.24

-19%

-0.19
vs -0.20

Q3.24

-18%

-0.18
vs -0.19

Q4.24

-35%

-0.35
vs -0.18

Q1.25

+33%

0.33
vs -0.35

Q2.25

-31%

-0.31
vs 0.33

Institutionnal Ownership

N/A

Q3.23

NA
vs NA

Q4.23

NA
vs NA

Q1.24

NA
vs NA

Q2.24

NA
vs NA

Q3.24

NA
vs NA

Q4.24

NA
vs NA

Q1.25

NA
vs NA

Q2.25

NA
vs NA

Q3.25

NA
vs NA

Q4.25

NA
vs NA

Company Description

2.21USD

N/A

4.82x

0.89x

0.0

-48.2%

$-0.8

$37M

$1.57

$31M

Earnings Growth

Latest News

Latest News

Latest News

Earnings Growth

$37M

$1.57

$31M

Company Description

2.21USD

N/A

4.82x

0.89x

0.0

-48.2%

$-0.8